|
Market Closed -
OTC Markets
20:57:31 15/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.0170 USD | -9.09% |
|
-5.56% | -72.31% |
| 08-13 | CV Sciences, Inc., Q2 2026 Earnings Call, Aug 13, 2026 | |
| 08-13 | CV Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 3.84M 3.33M 3.14M 2.85M 5.34M 368M 5.38M 37.53M 14.44M 187M 14.42M 14.1M 596M | P/E 2024 |
-2.48x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 5.56M 4.81M 4.55M 4.12M 7.73M 533M 7.79M 54.32M 20.9M 270M 20.87M 20.41M 862M | EV / Sales 2024 |
0.42x | EV / Sales 2025 | 0.95x |
| Free-Float |
78.62% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CV Sciences, Inc.
| 1 day | -9.09% | ||
| 1 week | -5.56% | ||
| Current month | -9.09% | ||
| 1 month | -32.00% | ||
| 3 months | -26.09% | ||
| 6 months | -60.47% | ||
| Current year | -72.31% |
| 1 week | 0.02 |  | 0.02 |
| 1 month | 0.01 | | 0.02 |
| Current year | 0.01 | | 0.1 |
| 1 year | 0.01 | | 0.1 |
| 3 years | 0.01 | | 0.1 |
| 5 years | 0.01 | | 0.27 |
| 10 years | 0.01 | | 9.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 30/05/2018 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 14/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 30/05/2018 |
Jamie Corroon
BRD | Director/Board Member | 56 | 20/07/2022 |
William McCorkle
BRD | Director/Board Member | 58 | 20/10/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/02/25 | Free | Chief Executive Officer | 3,000,000 | 1.6281% | ||
| 18/02/25 | Free | Director | 500,000 | 0.2714% | ||
| 18/02/25 | Free | Director | 500,000 | 0.2714% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -9.09% | -5.56% | -49.85% | -66.00% | 3.84M | |
| -0.19% | +1.09% | +51.85% | +97.36% | 1,013B | |
| +0.33% | -0.71% | +50.62% | +65.50% | 644B | |
| +0.49% | +5.73% | +20.88% | +72.92% | 465B | |
| +0.71% | +4.26% | +40.29% | +40.53% | 352B | |
| +1.32% | +3.06% | +18.79% | +25.06% | 264B | |
| +1.01% | +4.76% | +7.56% | +13.76% | 253B | |
| -1.53% | -4.46% | +36.90% | +44.08% | 203B | |
| -0.20% | -4.26% | -22.97% | -57.47% | 188B | |
| -0.08% | -0.23% | +30.00% | +93.34% | 181B | |
| Average | -0.42% | -1.53% | +18.40% | +32.91% | 356.37B | |
| Weighted average by Cap. | +0.59% | +0.01% | +34.92% | +60.07% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 15.7M 13.6M 12.86M 11.65M 21.86M 1.51B 22.02M 154M 59.06M 764M 58.99M 57.68M 2.44B | 13.79M 11.94M 11.29M 10.23M 19.19M 1.32B 19.33M 135M 51.85M 671M 51.8M 50.65M 2.14B |
| Net income | -2.39M -2.07M -1.96M -1.78M -3.33M -230M -3.36M -23.4M -9M -116M -8.99M -8.79M -371M | -958K -830K -785K -710K -1.33M -91.9M -1.34M -9.36M -3.6M -46.6M -3.6M -3.52M -149M |
| Net Debt | 325K 282K 266K 241K 452K 31.18M 456K 3.18M 1.22M 15.81M 1.22M 1.19M 50.41M | 1.72M 1.49M 1.41M 1.27M 2.39M 165M 2.41M 16.79M 6.46M 83.56M 6.45M 6.31M 266M |
Employees
43
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/09/26 | US$0.0170 | -9.09% | 350,925 |
| 14/09/26 | US$0.0187 | +11.31% | 540,909 |
| 11/09/26 | US$0.0168 | -12.73% | 1,196,368 |
| 10/09/26 | US$0.0193 | +1.42% | 22,931 |
| 09/09/26 | US$0.0190 | +5.44% | 42,430 |
- Stock Market
- Stocks
- CVSI Stock
Select your edition
All financial news and data tailored to specific country editions
